These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 18452879

  • 21. Pharmacological rescue of hERG currents carried out by G604S and wide type hERG co-expression.
    Huo J, Zhang A, Guo X, Qiang H, Liu P, Bai L, Ma A.
    Clin Exp Pharmacol Physiol; 2016 Sep; 43(9):851-61. PubMed ID: 27199074
    [Abstract] [Full Text] [Related]

  • 22. Pharmacological activation of IKr impairs conduction in guinea pig hearts.
    Larsen AP, Olesen SP, Grunnet M, Poelzing S.
    J Cardiovasc Electrophysiol; 2010 Aug 01; 21(8):923-9. PubMed ID: 20163495
    [Abstract] [Full Text] [Related]

  • 23. [HERG K+ channel, the target of anti-arrhythmias drugs].
    Guan FY, Yang SJ.
    Yao Xue Xue Bao; 2007 Jul 01; 42(7):687-91. PubMed ID: 17882949
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Pharmacological activation of rapid delayed rectifier potassium current suppresses bradycardia-induced triggered activity in the isolated guinea pig heart.
    Hansen RS, Olesen SP, Grunnet M.
    J Pharmacol Exp Ther; 2007 Jun 01; 321(3):996-1002. PubMed ID: 17325228
    [Abstract] [Full Text] [Related]

  • 26. High affinity open channel block by dofetilide of HERG expressed in a human cell line.
    Snyders DJ, Chaudhary A.
    Mol Pharmacol; 1996 Jun 01; 49(6):949-55. PubMed ID: 8649354
    [Abstract] [Full Text] [Related]

  • 27. Disopyramide is an effective inhibitor of mutant HERG K+ channels involved in variant 1 short QT syndrome.
    McPate MJ, Duncan RS, Witchel HJ, Hancox JC.
    J Mol Cell Cardiol; 2006 Sep 01; 41(3):563-6. PubMed ID: 16842817
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Investigating the utility of adult zebrafish ex vivo whole hearts to pharmacologically screen hERG channel activator compounds.
    Hull CM, Genge CE, Hobbs Y, Rayani K, Lin E, Gunawan M, Shafaattalab S, Tibbits GF, Claydon TW.
    Am J Physiol Regul Integr Comp Physiol; 2019 Dec 01; 317(6):R921-R931. PubMed ID: 31664867
    [Abstract] [Full Text] [Related]

  • 30. Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies.
    Ducroq J, Printemps R, Guilbot S, Gardette J, Salvetat C, Le Grand M.
    J Pharmacol Toxicol Methods; 2007 Dec 01; 56(2):159-70. PubMed ID: 17604185
    [Abstract] [Full Text] [Related]

  • 31. Use-dependent modulation of myocardial conduction by a new class of HERG agonists: deal breaker or cherry on top?
    Akar FG.
    J Cardiovasc Electrophysiol; 2010 Aug 01; 21(8):930-2. PubMed ID: 20367661
    [No Abstract] [Full Text] [Related]

  • 32. The human ether-a-go-go-related gene (hERG) current inhibition selectively prolongs action potential of midmyocardial cells to augment transmural dispersion.
    Yasuda C, Yasuda S, Yamashita H, Okada J, Hisada T, Sugiura S.
    J Physiol Pharmacol; 2015 Aug 01; 66(4):599-607. PubMed ID: 26348084
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
    Gordon E, Lozinskaya IM, Lin Z, Semus SF, Blaney FE, Willette RN, Xu X.
    Mol Pharmacol; 2008 Mar 01; 73(3):639-51. PubMed ID: 18042732
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide.
    Paul AA, Witchel HJ, Hancox JC.
    Biochem Biophys Res Commun; 2001 Feb 09; 280(5):1243-50. PubMed ID: 11162661
    [Abstract] [Full Text] [Related]

  • 37. hERG channel agonist NS1643 strongly inhibits invasive astrocytoma cell line SMA-560.
    Benn KW, Yuan PH, Chong HK, Stylii SS, Luwor RB, French CR.
    PLoS One; 2024 Feb 09; 19(9):e0309438. PubMed ID: 39240809
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A multiscale computational modelling approach predicts mechanisms of female sex risk in the setting of arousal-induced arrhythmias.
    Yang PC, Perissinotti LL, López-Redondo F, Wang Y, DeMarco KR, Jeng MT, Vorobyov I, Harvey RD, Kurokawa J, Noskov SY, Clancy CE.
    J Physiol; 2017 Jul 15; 595(14):4695-4723. PubMed ID: 28516454
    [Abstract] [Full Text] [Related]

  • 40. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D, Wendt-Nordahl G, Röckl K, Ficker E, Brown AM, Kiehn J.
    J Pharmacol Exp Ther; 2001 May 15; 297(2):753-61. PubMed ID: 11303067
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.